Mphasis announced that Mr. Davinder Singh Brar, Independent Director has been elected as the Chairman of the company. Mr. Brar replaces Dr. Friedrich Froeschl, who resigned from the Board due to health reasons. Mr. Brar has been involved with the Life Sciences industry for nearly four decades. Post his tenure at Ranbaxy, he promoted Contract Research and Manufacturing Services companies; GVK Biosciences and Inogent Labs. He serves on the boards of Maruti Suzuki India Limited, Wockhardt Limited, Gland Pharma Limited and Mountain Trail Foods Private Limited apart from being a Special Advisor to Bain Consulting.
Mphasis also announced two new appointments to their Board. Ms. Jan Kathleen Hier (Jan Hier-King) as an Independent Director and Mr. Jeff Thomas Ricci as non-executive additional director. Ms. Hier-King is currently a partner with a start-up named Bicycle Financial. Formerly, she was the Executive Vice President at Charles Schwab responsible for centralized support services including Schwab Technology Services, Operational Services, Corporate Project Management, Operational Risk Management and Offshore Services. Mr. Ricci is currently Senior Vice President and Controller for Hewlett Packard (HP) Enterprise responsible for all accounting and external financial reporting activities for HP Enterprise.
“I am honored to have been elected as Chairman of the Mphasis Board. I have seen the Company go through various industry cycles and always emerge stronger. Together with the other Board members and Management, we hope to steer the organization to greater heights” said Mr. Brar.